(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||||||||||||||||||||||||||||||||
Ordinary Shares, par value $0.0001 per share* | 06160 | The Stock Exchange of Hong Kong Limited |
Exhibit No. | Description | |||||||
99.1 | Financial Information, furnished herewith | |||||||
104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL | |||||||
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL |
BEIGENE, LTD. | ||||||||||||||||||||||||||
Date: April 25, 2023 | By: | /s/ Chan Lee | ||||||||||||||||||||||||
Name: | Chan Lee | |||||||||||||||||||||||||
Title: | Senior Vice President, General Counsel |
For the year ended December 31, 2022 | For the year ended December 31, 2021 | |||||||||||||||||||
By Region | Revenue | COGS | Gross Margin ratio | Revenue | COGS | Gross Margin ratio | ||||||||||||||
China | 840,032 | 276,729 | 67.1% | 517,173 | 162,976 | 68.5% | ||||||||||||||
Ex-China | 575,889 | 9,746 | 98.3% | 659,110 | 1,930 | 99.7% | ||||||||||||||
Total | 1,415,921 | 286,475 | 1,176,283 | 164,906 |
Pipeline Products/ Projects | Year ended December 31, 2022 | Year ended December 31, 2021 | ||||||
Zanubrutinib | 126,959 | 141,495 | ||||||
Tislelizumab | 88,935 | 163,986 | ||||||
Pamiparib | 11,606 | 14,419 | ||||||
Ociperlimab (BGB-A1217) | 106,608 | 65,102 | ||||||
Bcl-2 (BGB-11417) | 22,377 | 10,978 | ||||||
OX40 (BGB-A445) | 11,215 | 2,225 | ||||||
Other R&D projects | 101,797 | 79,556 | ||||||
R&D collaboration projects | 167,620 | 198,964 | ||||||
Subtotal of external R&D expenses | 637,117 | 676,725 | ||||||
Subtotal of internal R&D expenses | 1,003,391 | 782,514 | ||||||
Total | 1,640,508 | 1,459,239 |
Item | Unit | Production or purchase quantity for the year ended December 31, 2022 | Sales quantity for the year ended December 31, 2022 | Stock quantity as of December 31, 2022 | ||||||||||
Key products | vials | 3,281,200 | 2,674,200 | 1,539,800 |
Cover |
Apr. 25, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Apr. 25, 2023 |
Entity Registrant Name | BEIGENE, LTD. |
Entity Incorporation, State or Country Code | E9 |
Entity Address, Address Line One | 94 Solaris Avenue, Camana Bay |
Entity Address, City or Town | Grand Cayman |
Entity Address, Postal Zip Code | KY1-1108 |
Entity Address, Country | KY |
Written Communications | false |
Soliciting Material | false |
City Area Code | (345) |
Local Phone Number | 949-4123 |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share |
Trading Symbol | BGNE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001651308 |
Amendment Flag | false |
Entity Tax Identification Number | 98-1209416 |
Entity File Number | 001-37686 |
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end
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end